Novo Nordisk Asks FDA to Update Tresiba Label on HypoglycemiaByMary CaffreyMay 31st 2017While regulators long ago saw enough cardiovascular safety data to approve insulin degludec, full trial results will be presented June 12 at the American Diabetes Association Scientific Sessions in San Diego.